ICON PUBLIC LIMITED COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 316 USD | -0.83% |
|
-0.60% | +11.63% |
Presenter SpeechKate Haven (Executives)Welcome, everyone. Thank you so much for joining us tod...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
Calendar
23/07/2024
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
316
USD
Average target price
363.6
USD
Spread / Average Target
+15.06%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +11.63% | 26.13B | |
| +35.14% | 51.51B | |
| -7.43% | 39.03B | |
| +35.88% | 38.91B | |
| -10.62% | 26.68B | |
| -17.77% | 19.91B | |
| +40.52% | 13.71B | |
| +30.70% | 12.38B | |
| -3.41% | 11.74B | |
| -11.32% | 10.8B |
- Stock Market
- Equities
- ICLR Stock
- News ICON Public Limited Company
- Transcript : ICON Public Limited Company - Analyst/Investor Day
